These results are compatible with the Maitra et al. study showing that the expression of COX-2 is significantly higher in high-grade PanIN lesions and poorly differentiated adenocarcinomas than in low-grade PanINs and moderately differentiated adenocarcinomas [50]. The gene discussed is PTGS2; the disease is adenocarcinoma.